ATE364387T1 - Zellbasierte gentherapie für das lungensystem - Google Patents
Zellbasierte gentherapie für das lungensystemInfo
- Publication number
- ATE364387T1 ATE364387T1 AT99944205T AT99944205T ATE364387T1 AT E364387 T1 ATE364387 T1 AT E364387T1 AT 99944205 T AT99944205 T AT 99944205T AT 99944205 T AT99944205 T AT 99944205T AT E364387 T1 ATE364387 T1 AT E364387T1
- Authority
- AT
- Austria
- Prior art keywords
- cell
- based gene
- gene therapy
- patient
- circulation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/44—Oxidoreductases (1)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/36—Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1858—Platelet-derived growth factor [PDGF]
- A61K38/1866—Vascular endothelial growth factor [VEGF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- A61K48/0075—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the delivery route, e.g. oral, subcutaneous
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y114/00—Oxidoreductases acting on paired donors, with incorporation or reduction of molecular oxygen (1.14)
- C12Y114/13—Oxidoreductases acting on paired donors, with incorporation or reduction of molecular oxygen (1.14) with NADH or NADPH as one donor, and incorporation of one atom of oxygen (1.14.13)
- C12Y114/13039—Nitric-oxide synthase (NADPH dependent) (1.14.13.39)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biotechnology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Engineering & Computer Science (AREA)
- Toxicology (AREA)
- Dermatology (AREA)
- Biomedical Technology (AREA)
- Developmental Biology & Embryology (AREA)
- Virology (AREA)
- Pulmonology (AREA)
- Wood Science & Technology (AREA)
- Vascular Medicine (AREA)
- Biophysics (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/CA1999/000869 WO2001021184A1 (en) | 1999-09-23 | 1999-09-23 | Cell-based gene therapy for the pulmonary system |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE364387T1 true ATE364387T1 (de) | 2007-07-15 |
Family
ID=4173386
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT99944205T ATE364387T1 (de) | 1999-09-23 | 1999-09-23 | Zellbasierte gentherapie für das lungensystem |
Country Status (11)
Country | Link |
---|---|
EP (2) | EP1220679B1 (de) |
JP (1) | JP2003509463A (de) |
AT (1) | ATE364387T1 (de) |
AU (1) | AU5724499A (de) |
BR (1) | BR9917500A (de) |
CA (1) | CA2383093A1 (de) |
DE (1) | DE69936320T2 (de) |
ES (1) | ES2546937T3 (de) |
IL (3) | IL148826A0 (de) |
MX (1) | MXPA02003131A (de) |
WO (1) | WO2001021184A1 (de) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11975030B2 (en) | 2019-03-19 | 2024-05-07 | Figene, Llc | Treatment of chronic obstructive pulmonary disease and lung degeneration using activated fibroblasts and exosome derivatives thereof |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5219740A (en) * | 1987-02-13 | 1993-06-15 | Fred Hutchinson Cancer Research Center | Retroviral gene transfer into diploid fibroblasts for gene therapy |
JPH04507041A (ja) * | 1988-12-13 | 1992-12-10 | アメリカ合衆国 | 遺伝工学により修飾された内皮細胞およびその利用方法 |
US5240846A (en) * | 1989-08-22 | 1993-08-31 | The Regents Of The University Of Michigan | Gene therapy vector for cystic fibrosis |
WO1992015676A1 (en) * | 1991-03-08 | 1992-09-17 | The Salk Institute For Biological Studies | Somatic cell gene therapy |
WO1993013807A1 (en) * | 1992-01-10 | 1993-07-22 | Georgetown University | A method of administering genetically engineered endothelial cells to sites of angiogenesis for effecting genetic therapy |
CA2086844A1 (en) * | 1993-01-07 | 1994-07-08 | Ian D. Dube | Method and product of gene transfer into cells |
CA2260771A1 (en) * | 1996-07-17 | 1998-01-22 | The General Hospital Corporation | Method of inducing vasodilation and treating pulmonary hypertension using adenoviral-mediated transfer of the nitric oxide synthase gene |
ATE287271T1 (de) * | 1996-11-01 | 2005-02-15 | Ark Therapeutics Ltd | Verwendung von vegf zur herstellung eines medikaments zur behandlung oder verhinderung der intimalen hyperplasie und verabreichungsgerät |
US5980887A (en) * | 1996-11-08 | 1999-11-09 | St. Elizabeth's Medical Center Of Boston | Methods for enhancing angiogenesis with endothelial progenitor cells |
EP0893493A3 (de) * | 1997-07-21 | 2002-12-04 | Aventis Pharma Deutschland GmbH | Genetisch veränderte Zellen und deren Verwendung in der Prophylaxe oder Therapie von Erkrankungen |
US6147109A (en) * | 1997-10-14 | 2000-11-14 | The General Hospital Corporation | Upregulation of Type III endothelial cell Nitric Oxide Synthase by HMG-CoA reductase inhibitors |
JP2002502608A (ja) * | 1998-02-06 | 2002-01-29 | コラテラル・セラピューティックス・インコーポレイテッド | 血管新生促進因子である血管内皮細胞成長因子:vegfの変異体 |
CA2266805C (en) * | 1998-03-27 | 2015-04-28 | An-Go-Gen Inc. | Cell-based gene therapy in the treatment of pulmonary disorders |
CA2227425A1 (en) * | 1998-03-27 | 1999-09-27 | An-Go-Gen Inc. | Cell-based gene therapy |
-
1999
- 1999-09-23 AT AT99944205T patent/ATE364387T1/de active
- 1999-09-23 MX MXPA02003131A patent/MXPA02003131A/es active IP Right Grant
- 1999-09-23 AU AU57244/99A patent/AU5724499A/en not_active Abandoned
- 1999-09-23 JP JP2001524610A patent/JP2003509463A/ja active Pending
- 1999-09-23 EP EP99944205A patent/EP1220679B1/de not_active Expired - Lifetime
- 1999-09-23 IL IL14882699A patent/IL148826A0/xx unknown
- 1999-09-23 DE DE1999636320 patent/DE69936320T2/de not_active Expired - Lifetime
- 1999-09-23 EP EP07009031.1A patent/EP1839667B1/de not_active Expired - Lifetime
- 1999-09-23 CA CA 2383093 patent/CA2383093A1/en not_active Abandoned
- 1999-09-23 ES ES07009031.1T patent/ES2546937T3/es not_active Expired - Lifetime
- 1999-09-23 WO PCT/CA1999/000869 patent/WO2001021184A1/en active Application Filing
- 1999-09-23 BR BR9917500-2A patent/BR9917500A/pt not_active IP Right Cessation
-
2002
- 2002-03-21 IL IL14882602A patent/IL148826A/en not_active IP Right Cessation
-
2008
- 2008-07-17 IL IL192893A patent/IL192893A/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
EP1220679B1 (de) | 2007-06-13 |
EP1220679A1 (de) | 2002-07-10 |
EP1839667A3 (de) | 2010-04-14 |
IL148826A (en) | 2010-12-30 |
CA2383093A1 (en) | 2001-03-29 |
IL148826A0 (en) | 2002-09-12 |
IL192893A0 (en) | 2009-02-11 |
JP2003509463A (ja) | 2003-03-11 |
DE69936320D1 (de) | 2007-07-26 |
BR9917500A (pt) | 2002-05-21 |
EP1839667B1 (de) | 2015-06-17 |
ES2546937T3 (es) | 2015-09-30 |
IL192893A (en) | 2014-03-31 |
EP1839667A2 (de) | 2007-10-03 |
MXPA02003131A (es) | 2003-08-20 |
WO2001021184A1 (en) | 2001-03-29 |
AU5724499A (en) | 2001-04-24 |
DE69936320T2 (de) | 2008-02-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE385810T1 (de) | Verwendung von dna oder rna zur herstellung eines medikaments zur behandlung von tumoren | |
NZ505011A (en) | Expression vectors and cell lines expressing VEGF-D and method of treating melanomas | |
SE9702860L (sv) | Användning av en stam av Lactobacillus för tillverkning av ett läkemedel för reduktion av fibrinogenhalten i blod | |
DE69331526D1 (de) | Adenovirus gelenkter gen-transfer zum herz- und glatten vaskularen muskel | |
EP0235162A4 (de) | Cdns und gen für menschliches angiogenin (angiogenesis-faktor) und expression. | |
ATE319827T1 (de) | Polypeptid, das die differenzierung unterdrueckt | |
SE8703625D0 (sv) | New medical use | |
FI955552A0 (fi) | Adenoviraalisia eläinperäisiä vektoreita ja niiden käyttö geeniterapiassa | |
NZ223506A (en) | Tissue factor protein, dna encoding it, vectors, host cells, production of the protein and pharmaceutical compositions | |
NO963742L (no) | Fremgangsmåte til å stimulere hematopoese med hemaglobin | |
ATE420156T1 (de) | Methode zur einführung von genetischem material in zellen | |
AU5464000A (en) | Recombinant adenoviral vectors for cell specific infection and genome integration and expressing chimeric fiber proteins | |
NZ505063A (en) | Pharmaceutical use of long pentraxin PTX3 in treating tumour conditions | |
GR3026602T3 (en) | Morphogen-induced liver regeneration. | |
MD545G2 (ro) | Preparat medicamentos | |
ATE364387T1 (de) | Zellbasierte gentherapie für das lungensystem | |
El-Batouty et al. | Comparative evaluation of the effects of ultrasonic and ultraviolet irradiation on tissue regeneration | |
EP0315118A3 (de) | Endothelin kodierendes DNA und dessen Verwendung | |
NZ335401A (en) | Therapeutic uses of BPI protein products in cystic fibrosis patients | |
NZ299257A (en) | Treating purulent material (eg pulmonary disease) accumulation in patients using deamidated DNase | |
ATE120491T1 (de) | Ausgeglichenes, konstitutives, induzierbares transkriptionssystem. | |
WO2000017375A3 (en) | Method to treat haemophilia by in vivo gene therapy with retroviral vectors | |
ATE128964T1 (de) | Anwendung von beta-alethin in zellkultur und therapie. | |
GB0202410D0 (en) | Treatment of IL deficiencies | |
GB8727493D0 (en) | Epidermal growth factor |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1220679 Country of ref document: EP |